Cellular effects of adamantane derivatives in P-glycoprotein leukemia cells
Open Life Sciences · 23.01.2026 · 21 (1)
DOI: 10.1515/biol-2025-1340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Life Sciences, online erschienen am 26.06.2026. Verfasst von Natalia Dostalkova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinskeho 9, S…. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences, Slovak Agency for Research and Development.
Abstract (Originalsprache)
Acute myeloid leukemia is a severe hematologic malignancy that predominantly affects older adults and is characterized by high biological variability. One of the main challenges in its treatment is the development of multidrug resistance, often mediated by the overexpression of P-glycoprotein (ABCB1). This transport protein actively expels cytotoxic drugs from cells, reducing the effectiveness of chemotherapy and worsening patient prognosis. Although several generations of P-glycoprotein inhibitors have been developed, their clinical use is significantly limited due to their negative side effects. In recent years, attention has shifted toward natural substances and well-known drugs with broad applications. A promising candidate is amantadine, a lipophilic compound with a stable structure, originally used to treat influenza and Parkinson’s disease. This study focuses on investigating the potential of its derivatives in combating multidrug resistance in acute myeloid leukemia. The results demonstrate that the newly synthesized adamantane derivatives, particularly E-A2, exhibit significant cytotoxic activity in acute myeloid leukemia cell lines, including P-glycoprotein-expressing resistant variants. Importantly, E-A2 was able to induce both apoptotic and necrotic cell death and maintained its activity in multidrug resistant models.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinskeho 9, SK-81237, Bratislava, Slovak Republic.
- Department of Organic Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinskeho 9, SK-81237, Bratislava, Slovak Republic.
ORCID-Profile: Lucia Sofrankova, Jana Spaldova, Branislav Pavilek, Lakatos Boris
Förderung
- Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences
- Slovak Agency for Research and Development
Zitieren
APA
Dostalkova, N., Sofrankova, L., Spaldova, J., Pavilek, B., Pisarova, E., & Boris, L. (2026). Cellular effects of adamantane derivatives in P-glycoprotein leukemia cells. Open Life Sciences, 21(1). https://doi.org/10.1515/biol-2025-1340
Vancouver
Dostalkova N, Sofrankova L, Spaldova J, Pavilek B, Pisarova E, Boris L. Cellular effects of adamantane derivatives in P-glycoprotein leukemia cells. Open Life Sciences. 2026;21(1). doi:10.1515/biol-2025-1340
BibTeX
@article{Dostalkova2026,
author = {Dostalkova, Natalia and Sofrankova, Lucia and Spaldova, Jana and Pavilek, Branislav and Pisarova, Ester and Boris, Lakatos},
title = {Cellular effects of adamantane derivatives in P-glycoprotein leukemia cells},
journal = {Open Life Sciences},
year = {2026},
volume = {21},
number = {1},
doi = {10.1515/biol-2025-1340}
}
EUVIMED